HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Association of Hypertension with Obesity and Metabolic Abnormalities among Chinese Children.

Abstract
A total of 8898 Chinese children (4580 boys and 4318 girls) aged 7-13 years in 6 cities of east China were recruited. Data on height, weight, waist circumference, blood pressure, serum lipid profiles, glucose, and insulin were collected. The overall prevalence of hypertension was 11.1%. Overweight and obese children had a higher risk of developing hypertension than their counterparts (29.1%, 17.4%, and 7.8%, resp.) (P = 0.0001). The means levels of triglycerides, glucose, insulin, and HOMA-IR (1.0 mmol/L, 4.5 mmol/L, 8.4 mU/mL and 1.7, resp.) among hypertensive children were all significantly higher than their normotensive counterparts (0.8 mmol/L, 4.5 mmol/L, 5.9 mU/mL, and 1.2, resp.) (P = 0.0001). Compared with the healthy children, the risk (odds ratio, OR) of having hypertension among children with high triglycerides, hyperglycemia, and metabolic syndrome was 1.4 (95% confidence interval (CI): 1.0-2.0, P = 0.0334), 1.5 (95% CI: 0.9-2.5, P = 0.0890), and 2.8 (95%CI: 1.5-5.4, P = 0.0014), respectively, after controlling for age, gender, BMI, income level, parents' education level and puberty. In conclusion, overweight and obese children have higher risk of having hypertension and children with dyslipidemia, hyperglycemia, and metabolic syndrome and higher HOMA-IR have higher risk of developing hypertension.
AuthorsHaiquan Xu, Xiaoqi Hu, Qian Zhang, Songming Du, Hongyun Fang, Ying Li, Jun Ma, Tingyu Li, Lin Du, Hongwei Guo, Guifa Xu, Ailing Liu
JournalInternational journal of hypertension (Int J Hypertens) Vol. 2011 Pg. 987159 ( 2011) ISSN: 2090-0392 [Electronic] United States
PMID22187624 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: